{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,6]],"date-time":"2026-10-06T06:12:29Z","timestamp":1791267149956,"version":"4.1.0"},"reference-count":44,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2026,9,1]],"date-time":"2026-09-01T00:00:00Z","timestamp":1788220800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,9,1]],"date-time":"2026-09-01T00:00:00Z","timestamp":1788220800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,9,1]],"date-time":"2026-09-01T00:00:00Z","timestamp":1788220800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2026,9,1]],"date-time":"2026-09-01T00:00:00Z","timestamp":1788220800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2026,9,1]],"date-time":"2026-09-01T00:00:00Z","timestamp":1788220800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2026,9,1]],"date-time":"2026-09-01T00:00:00Z","timestamp":1788220800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2026,9,1]],"date-time":"2026-09-01T00:00:00Z","timestamp":1788220800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"funder":[{"DOI":"10.13039\/501100007765","name":"Shenyang Municipal Bureau of Science and Technology","doi-asserted-by":"publisher","award":["RC230675"],"award-info":[{"award-number":["RC230675"]}],"id":[{"id":"10.13039\/501100007765","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100005047","name":"Natural Science Foundation of Liaoning Province","doi-asserted-by":"publisher","award":["2024-MS-085"],"award-info":[{"award-number":["2024-MS-085"]}],"id":[{"id":"10.13039\/501100005047","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100018617","name":"Liaoning Revitalization Talents Program","doi-asserted-by":"publisher","award":["XLYC2403159"],"award-info":[{"award-number":["XLYC2403159"]}],"id":[{"id":"10.13039\/501100018617","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["European Journal of Medicinal Chemistry"],"published-print":{"date-parts":[[2026,9]]},"DOI":"10.1016\/j.ejmech.2026.118878","type":"journal-article","created":{"date-parts":[[2026,4,18]],"date-time":"2026-04-18T15:23:14Z","timestamp":1776525794000},"page":"118878","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":1,"special_numbering":"C","title":["Discovery of anti-glaucoma agents with dual hCA II inhibitory and nitric oxide-releasing activity and their neuroprotective effects"],"prefix":"10.1016","volume":"313","author":[{"given":"Xin","family":"Wang","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yitong","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zhongyu","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yixiao","family":"Zhao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jihong","family":"Han","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mengbi","family":"Guo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xinqi","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kaiqi","family":"Yu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yanhua","family":"Mou","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-4933-4226","authenticated-orcid":false,"given":"Zhuang","family":"Hou","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chun","family":"Guo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Cheng","family":"Peng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.ejmech.2026.118878_bib1","doi-asserted-by":"crossref","first-page":"1788","DOI":"10.1016\/S0140-6736(23)01289-8","article-title":"Glaucoma: now and beyond","volume":"402","author":"Jayaram","year":"2023","journal-title":"Lancet"},{"key":"10.1016\/j.ejmech.2026.118878_bib2","doi-asserted-by":"crossref","first-page":"217","DOI":"10.5530\/ctbp.2020.2.22","article-title":"Glaucoma: a review","volume":"14","author":"Thakur","year":"2020","journal-title":"Curr. Trends Biotechnol. Pharm."},{"key":"10.1016\/j.ejmech.2026.118878_bib3","first-page":"253","article-title":"Glaucoma: diagnosis and management","volume":"107","author":"Michels","year":"2023","journal-title":"Am. Fam. Physician"},{"key":"10.1016\/j.ejmech.2026.118878_bib4","doi-asserted-by":"crossref","first-page":"493","DOI":"10.1016\/j.mcna.2021.01.004","article-title":"Glaucoma","volume":"105","author":"Kang","year":"2021","journal-title":"Med. Clin. N. Am."},{"key":"10.1016\/j.ejmech.2026.118878_bib5","doi-asserted-by":"crossref","first-page":"107","DOI":"10.1080\/08164622.2023.2300295","article-title":"Glaucoma: challenges and opportunities","volume":"107","author":"Kalloniatis","year":"2024","journal-title":"Clin. Exp. Optom."},{"key":"10.1016\/j.ejmech.2026.118878_bib6","doi-asserted-by":"crossref","first-page":"2000","DOI":"10.3390\/biomedicines12092000","article-title":"Glaucoma: current and new therapeutic approaches","volume":"12","author":"Lee","year":"2024","journal-title":"Biomedicines"},{"key":"10.1016\/j.ejmech.2026.118878_bib7","doi-asserted-by":"crossref","first-page":"721","DOI":"10.1136\/bjo.77.11.721","article-title":"The effect ofpilocarpine on the glaucomatous visual field","volume":"77","author":"Webster","year":"1993","journal-title":"Br. J. Ophthalmol."},{"key":"10.1016\/j.ejmech.2026.118878_bib8","doi-asserted-by":"crossref","first-page":"1514","DOI":"10.1001\/archopht.1995.01100120044006","article-title":"Effects of brimonidine on aqueous humor dynamics in human eyes","volume":"113","author":"Toris","year":"1995","journal-title":"Arch. Ophthalmol."},{"key":"10.1016\/j.ejmech.2026.118878_bib9","doi-asserted-by":"crossref","first-page":"2045","DOI":"10.1001\/archopht.1978.03910060433007","article-title":"The mechanism of timolol in lowering intraocular pressure: in the normal eye","volume":"96","author":"Coakes","year":"1978","journal-title":"Arch. Ophthalmol."},{"key":"10.1016\/j.ejmech.2026.118878_bib10","article-title":"Clinical pharmacology and pharmacogenetics of prostaglandin analogues in glaucoma","volume":"13","author":"Zhou","year":"2022","journal-title":"Front. Pharmacol."},{"key":"10.1016\/j.ejmech.2026.118878_bib11","doi-asserted-by":"crossref","first-page":"2519","DOI":"10.2147\/DDDT.S515166","article-title":"Rho kinase inhibitors in glaucoma management: current perspectives and future directions","volume":"19","author":"Chatzimichail","year":"2025","journal-title":"Drug. Des. Devel. Ther."},{"key":"10.1016\/j.ejmech.2026.118878_bib12","article-title":"Recent overviews on the drug delivery aspects and applications of brinzolamide for the management of glaucoma","volume":"6","author":"Sharma","year":"2023","journal-title":"Health Sci. Rev."},{"key":"10.1016\/j.ejmech.2026.118878_bib13","first-page":"2","article-title":"A review of ocular and systemic side effects in glaucoma pharmacotherapy","volume":"3","author":"Li","year":"2025","journal-title":"J. Clin. Transl. Ophthalmol."},{"key":"10.1016\/j.ejmech.2026.118878_bib14","doi-asserted-by":"crossref","first-page":"278","DOI":"10.1016\/j.tvjl.2014.12.017","article-title":"A review of the pharmacology of carbonic anhydrase inhibitors for the treatment of glaucoma in dogs and cats","volume":"203","author":"Ma\u015blanka","year":"2015","journal-title":"Vet. J."},{"key":"10.1016\/j.ejmech.2026.118878_bib15","doi-asserted-by":"crossref","DOI":"10.1016\/j.bioorg.2025.108224","article-title":"Carbonic anhydrase inhibitors: structural insights and therapeutic potential","volume":"156","author":"Singh","year":"2025","journal-title":"Bioorg. Chem."},{"key":"10.1016\/j.ejmech.2026.118878_bib16","doi-asserted-by":"crossref","first-page":"6","DOI":"10.1016\/j.tips.2025.07.002","article-title":"Human carbonic anhydrase modulators: the past, present, and future","volume":"46","author":"Giovannuzzi","year":"2025","journal-title":"Trends Pharmacol. Sci."},{"key":"10.1016\/j.ejmech.2026.118878_bib17","article-title":"Recent advances in the medicinal chemistry of carbonic anhydrase inhibitors","volume":"209","author":"Kumar","year":"2020","journal-title":"Eur. J. Med. Chem."},{"key":"10.1016\/j.ejmech.2026.118878_bib18","doi-asserted-by":"crossref","first-page":"705","DOI":"10.1517\/13543776.2013.794788","article-title":"Antiglaucoma carbonic anhydrase inhibitors: a patent review","volume":"23","author":"Masini","year":"2013","journal-title":"Expert Opin. Ther. Pat."},{"key":"10.1016\/j.ejmech.2026.118878_bib19","first-page":"275","article-title":"Nitric oxide donating anti-glaucoma drugs:advances and prospects","volume":"18","author":"Mao","year":"2020","journal-title":"Chin. J. Nat. Med."},{"key":"10.1016\/j.ejmech.2026.118878_bib20","article-title":"Nonclinical development of NCX 470, a novel nitric oxide (NO)-donating, IOP lowering prostaglandin analog for glaucoma and ocular hypertension","volume":"60","author":"Bastia","year":"2019","journal-title":"Investig. Ophthalmol. Vis. Sci."},{"key":"10.1016\/j.ejmech.2026.118878_bib21","first-page":"736","article-title":"Effects of topical nipradilol, a beta-blocking agent with alpha-blocking and nitroglycerin-like activities, on aqueous humor dynamics and fundus circulation","volume":"39","author":"Kanno","year":"1998","journal-title":"Investig. Ophthalmol. Vis. Sci."},{"key":"10.1016\/j.ejmech.2026.118878_bib22","first-page":"593","article-title":"Discovery of novel NO-Donor containing hCA II inhibitors with retinal ganglion cell-protective effects for the efficient treatment of glaucoma","volume":"69","author":"Wang","year":"2026","journal-title":"J. Med. Chem."},{"key":"10.1016\/j.ejmech.2026.118878_bib23","doi-asserted-by":"crossref","first-page":"189","DOI":"10.1211\/jpp.60.2.0007","article-title":"Evaluation of the NO-releasing properties of NO-donor linkers","volume":"60","author":"Calderone","year":"2008","journal-title":"J. Pharm. Pharmacol."},{"key":"10.1016\/j.ejmech.2026.118878_bib24","doi-asserted-by":"crossref","first-page":"6588","DOI":"10.1021\/jm900561s","article-title":"Isosorbide-based aspirin prodrugs: integration of nitric oxide releasing groups","volume":"52","author":"Jones","year":"2009","journal-title":"J. Med. Chem."},{"key":"10.1016\/j.ejmech.2026.118878_bib25","doi-asserted-by":"crossref","first-page":"4218","DOI":"10.1021\/acs.orglett.8b01591","article-title":"TCFH-NMI: Direct access to N-Acyl imidazoliums for challenging amide bond formations","volume":"20","author":"Beutner","year":"2018","journal-title":"Org. Lett."},{"key":"10.1016\/j.ejmech.2026.118878_bib26","doi-asserted-by":"crossref","first-page":"5380","DOI":"10.1021\/acs.jmedchem.8b00625","article-title":"Discovery of \u03b2-adrenergic receptors blocker-carbonic anhydrase inhibitor hybrids for multitargeted antiglaucoma therapy","volume":"61","author":"Nocentini","year":"2018","journal-title":"J. Med. Chem."},{"key":"10.1016\/j.ejmech.2026.118878_bib27","doi-asserted-by":"crossref","DOI":"10.1016\/j.preteyeres.2020.100922","article-title":"The vital role for nitric oxide in intraocular pressure homeostasis","volume":"83","author":"Reina-Torres","year":"2021","journal-title":"Prog. Retin. Eye Res."},{"key":"10.1016\/j.ejmech.2026.118878_bib28","doi-asserted-by":"crossref","DOI":"10.1016\/j.mam.2023.101193","article-title":"Neuroprotection in glaucoma: mechanisms beyond intraocular pressure lowering","volume":"92","author":"Tribble","year":"2023","journal-title":"Mol. Aspects. Med."},{"key":"10.1016\/j.ejmech.2026.118878_bib29","doi-asserted-by":"crossref","first-page":"1239","DOI":"10.3390\/biom11081239","article-title":"Targeting the NLRP3 inflammasome in glaucoma","volume":"11","author":"Coyle","year":"2021","journal-title":"Biomolecules"},{"key":"10.1016\/j.ejmech.2026.118878_bib30","doi-asserted-by":"crossref","first-page":"2105","DOI":"10.1007\/s10753-024-02178-0","article-title":"Inhibiting NLRP3 inflammasome activation to alleviate retinal inflammation and protect the optic nerve of OPTN(E50K)mice","volume":"48","author":"Wang","year":"2025","journal-title":"Inflammation"},{"key":"10.1016\/j.ejmech.2026.118878_bib31","doi-asserted-by":"crossref","first-page":"257","DOI":"10.1080\/15321819.2020.1726774","article-title":"Biomarkers of inflammation and oxidative stress in ophthalmic disorders","volume":"41","author":"Ahmad","year":"2020","journal-title":"J. Immunoassay Immunochem."},{"key":"10.1016\/j.ejmech.2026.118878_bib32","doi-asserted-by":"crossref","first-page":"493","DOI":"10.1016\/S0039-6257(01)00211-9","article-title":"The draize eye Test","volume":"45","author":"Wilhelmus","year":"2001","journal-title":"Surv. Ophthalmol."},{"key":"10.1016\/j.ejmech.2026.118878_bib33","doi-asserted-by":"crossref","first-page":"4221","DOI":"10.1016\/S0021-9258(18)95800-X","article-title":"Esterase activities of human carbonic anhydrases B and C","volume":"242","author":"Verpoorte","year":"1967","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.ejmech.2026.118878_bib34","doi-asserted-by":"crossref","first-page":"3317","DOI":"10.1021\/acs.jmedchem.9b02090","article-title":"Discovery of potent dual-tailed benzenesulfonamide inhibitors of human carbonic anhydrases implicated in glaucoma and in vivo profiling of their intraocular pressure lowering action","volume":"63","author":"Fares","year":"2020","journal-title":"J. Med. Chem."},{"key":"10.1016\/j.ejmech.2026.118878_bib35","doi-asserted-by":"crossref","first-page":"337","DOI":"10.1038\/sj.bjp.0704879","article-title":"Protective effect of relaxin in cardiac anaphylaxis: involvement of the nitric oxide pathway","volume":"137","author":"Masini","year":"2002","journal-title":"Br. J. Pharmacol."},{"key":"10.1016\/j.ejmech.2026.118878_bib36","doi-asserted-by":"crossref","first-page":"11745","DOI":"10.1021\/acs.jmedchem.2c00600","article-title":"Identification of nitric oxide-donating ripasudil derivatives with intraocular pressure lowering and retinal ganglion cell protection activities","volume":"65","author":"Yang","year":"2022","journal-title":"J. Med. Chem."},{"key":"10.1016\/j.ejmech.2026.118878_bib37","doi-asserted-by":"crossref","first-page":"1611","DOI":"10.1021\/acs.jmedchem.3c02279","article-title":"Discovery of novel pyridazine-tethered sulfonamides as carbonic anhydrase II inhibitors for the management of glaucoma","volume":"67","author":"Tawfik","year":"2024","journal-title":"J. Med. Chem."},{"key":"10.1016\/j.ejmech.2026.118878_bib38","first-page":"172","article-title":"A study of experimental carbomer glaucoma and other experimental glaucoma in rabbits","volume":"38","author":"Xu","year":"2002","journal-title":"Zhonghua Yan Ke Za Zhi"},{"key":"10.1016\/j.ejmech.2026.118878_bib39","doi-asserted-by":"crossref","first-page":"73","DOI":"10.3390\/pharmaceutics17010073","article-title":"Retinal protection of new nutraceutical formulation","volume":"17","author":"Rosa","year":"2025","journal-title":"Pharmaceutics"},{"key":"10.1016\/j.ejmech.2026.118878_bib40","doi-asserted-by":"crossref","first-page":"45","DOI":"10.1186\/s40425-019-0521-4","article-title":"The IL-1\/IL-1 receptor axis and tumor cell released inflammasome adaptor ASC are key regulators of TSLP secretion by cancer associated fibroblasts in pancreatic cancer","volume":"7","author":"Brunetto","year":"2019","journal-title":"J. Immunother. Cancer"},{"key":"10.1016\/j.ejmech.2026.118878_bib41","doi-asserted-by":"crossref","first-page":"12625","DOI":"10.1080\/21655979.2022.2076499","article-title":"Gastrodin protects retinal ganglion cells from ischemic injury by activating phosphatidylinositol 3-kinase\/protein kinase B\/nuclear factor erythroid 2-related factor 2 (PI3K\/AKT\/Nrf2) signaling pathway","volume":"13","author":"Li","year":"2022","journal-title":"Bioengineered"},{"key":"10.1016\/j.ejmech.2026.118878_bib42","doi-asserted-by":"crossref","first-page":"70","DOI":"10.1021\/acs.chemrestox.0c00319","article-title":"Diclofenac sodium triggers p53-Dependent apoptosis in human corneal epithelial cells via ROS-Mediated crosstalk","volume":"34","author":"Li","year":"2021","journal-title":"Chem. Res. Toxicol."},{"key":"10.1016\/j.ejmech.2026.118878_bib43","doi-asserted-by":"crossref","first-page":"73","DOI":"10.1016\/S0887-2333(98)00064-2","article-title":"Interlaboratory validation of the in vitro eye irritation tests for cosmetic ingredients. (1) overview of the validation study and Draize scores for the evaluation of the tests","volume":"13","author":"Ohno","year":"1999","journal-title":"Toxicol. Vitro"},{"key":"10.1016\/j.ejmech.2026.118878_bib44","doi-asserted-by":"crossref","first-page":"1173","DOI":"10.1002\/jps.20627","article-title":"In vitro hemolysis: guidance for the pharmaceutical scientist","volume":"95","author":"Amin","year":"2006","journal-title":"J. Pharm. Sci."}],"container-title":["European Journal of Medicinal Chemistry"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0223523426003235?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0223523426003235?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,6,18]],"date-time":"2026-06-18T14:17:30Z","timestamp":1781792250000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0223523426003235"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,9]]},"references-count":44,"alternative-id":["S0223523426003235"],"URL":"https:\/\/doi.org\/10.1016\/j.ejmech.2026.118878","relation":{},"ISSN":["0223-5234"],"issn-type":[{"value":"0223-5234","type":"print"}],"subject":[],"published":{"date-parts":[[2026,9]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Discovery of anti-glaucoma agents with dual hCA II inhibitory and nitric oxide-releasing activity and their neuroprotective effects","name":"articletitle","label":"Article Title"},{"value":"European Journal of Medicinal Chemistry","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ejmech.2026.118878","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 Published by Elsevier Masson SAS.","name":"copyright","label":"Copyright"}],"article-number":"118878"}}